2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Reumatología Clínica (English Edition)
          Reumatología Clínica (English Edition)
          Elsevier BV
          21735743
          July 2017
          July 2017
          : 13
          : 4
          : 201-209
          Article
          10.1016/j.reumae.2016.04.015
          c2fa32b4-a55a-4b35-9bf7-2efcb403feea
          © 2017

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article